Innovation in biotechnology
Committed to R&D in the biotech sector
Biotech innovation is part of AMSlab’s DNA. Since its inception, our group has maintained an unwavering commitment to scientific and technological development as tools for process improvement and the development of new, faster, more reliable and cost-effective analytical methods.
AMSlab participates in various research, development and innovation projects, both in-house and in collaboration with other private or public entities at a regional, national and international level, always striving to offer new analytical solutions in the field of quality control and the detection and identification of compounds.
R&D projects
Cronic-DSP
Evaluation of the effects of diarrheal seafood toxins (DSP) after a continuous intake and its neurological implications.
Learn moreDigital BIOCoV
Early prediction of anti-COVID-19 activity on biomolecules present in fungi and microalgae through Machine Learning techniques integrating biological and chemical data.
Learn moreTACTICS
New analytical control techniques for the industrial transition towards a safe circular economy.
Learn moreResearch and innovation against coronavirus
Rapid and simple in-situ molecular detection of SARS-CoV-2, without instrumentation requirement, by means of LAMP.
Learn moreAgritox
Prevention and mitigation of mycotoxin contamination of food and feed caused by climate change.
Learn moreToxicrop
Cyanotoxins in irrigation water: monitoring, risk assessment and proposals for remediation.
Learn moreIO4COLON
Industrial research to discover new immunotherapy drugs for the treatment of colon cancer.
Learn moreAlertox-Net
Atlantic Area Network for introduction of innovative toxicity alert systems for safer seafood products.
Learn moreeMolExpert
Software system for managing cloud molecular and analytical data and the use of Artificial Intelligence.
Learn morePure marine biotoxins
Production of standards for healthcare and pharmacological research.
Learn moreOther grants
Check other grants and subsidies received by the companies that make up the AMSlab group.